Arno Therapeutics, Inc 4
4 · Arno Therapeutics, Inc · Filed Feb 26, 2014
Insider Transaction Report
Form 4
KENYON LAWRENCE A
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2014-02-24+223,445→ 223,445 totalExercise: $2.23Exp: 2024-02-24→ Common Stock (223,445 underlying)
Footnotes (1)
- [F1]Vests 25% on first anniversary date and thereafter will vest in 24 equal monthly installments.